Tocilizumab in the treatment of a polyostotic variant of fibrous dysplasia of bone

Rheumatology (Oxford). 2015 Sep;54(9):1747-9. doi: 10.1093/rheumatology/kev221. Epub 2015 Jun 11.

Authors

Hubert de Boysson¹, Alison Johnson², Naceur Hablani³, Walid Hajlaoui³, Christophe Auzary², Loïk Geffray²

Affiliations

¹ Department of Internal Medicine and h.deboysson@ch-lisieux.fr.
² Department of Internal Medicine and.
³ Department of Radiology, Centre Hospitalier Robert Bisson, Lisieux, France.

PMID: 26070936
DOI: 10.1093/rheumatology/kev221

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / pharmacology
Antibodies, Monoclonal, Humanized / therapeutic use*
Bone and Bones / drug effects
Bone and Bones / pathology
Chromogranins
Female
Fibrous Dysplasia, Polyostotic / drug therapy*
Fibrous Dysplasia, Polyostotic / genetics*
GTP-Binding Protein alpha Subunits, Gs / genetics
Humans
Mutation / genetics
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
Chromogranins
GNAS protein, human
GTP-Binding Protein alpha Subunits, Gs
tocilizumab